Advaxis Stock Analysis (NASDAQ:ADXS)

Add to My Stocks
$8.11 $0.12 (1.46%) ADXS stock closing price Jan 23, 2017 (Closing)
Watch Robo Advisor Video of ADXS Stock Analysis
Advaxis
Updated on : Jan 23, 2017
previous close
ADXS 8.1 (0%)
S&P 500 2265.2 (0%)
Closing Price On: Jan 23, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Biomed-Genetics
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2016-Q4
$million
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
-1916.8%
Sector Average:
-1.3%
5 Quarter Net Profit
Net Margins
2016-Q4
%
LTM Margin
Debt/Equity Ratio
Debt:
0.4M
Debt/Equity Ratio:
 0
Compared to the industry
Cash Flow
Operating cash flow:
$22.1M
Net Income:
-$21.7M
PROS      CONS
Low Debt Burden
FCF Margin
Recent Growth
Operating Margins
Net Margins
ROE
Rating: ★★★★★★★★★★ (0/5)
Other Metrics
Return on Equity:
-70.9%
Free Cash Flow Margin:
557.5%
Double Tap To Exit Full Screen
0:00
/

Advaxis Analysis Video

126 5 2

View Advaxis stock analysis video. This is our ADXS analyst opinion covering the buy and sell arguments for ADXS stock.

Advaxis, Inc. Stock Rating (1.2/5)

Our Advaxis stock opinion is based on fundamentals of the company. This Advaxis stock analysis is based on latest Q4 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.

Should you buy ADXS stock?

  • Advaxis has a lower debt burden than its peers in the Medical sector, with a debt/equity ratio of  0.
  • The company has a healthy free cash flow margin of 557.5%.

Should you sell ADXS stock?

  • Advaxis sales declined by -999% year on year in 2016 Q4.
  • Advaxis registered a negative operating margin of -1916.8% (average) over the Trailing Twelve Months (TTM).
  • Over the last 12 months, Advaxis had an average Net loss of -1843.6%.
  • Advaxis has a negative return on equity of -70.9%. This indicates that the firm is inefficient at generating profits.

Comments on this video and Advaxis stock